AC
EVH icon

Apogem Capital’s Evolent Health EVH Stock Holding History

Apogem Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,932
Closed -$1.18M – 36
2022
Q3 		$1.18M Hold
32,932
– – 1.18% 19
2022
Q2 		$1.01M Hold
32,932
– – 0.91% 29
2022
Q1 		$1.06M Hold
32,932
– – 0.73% 37
2021
Q4 		$911K Hold
32,932
– – 0.6% 56
2021
Q3 		$1.02M Sell
32,932
-1,745
-5% -$41.9K 0.65% 44
2021
Q2 		$732K Buy
+34,677
New +$695K 0.47% 79

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Apogem Capital's EVH Position: Q4 2022 in Review

Apogem Capital sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 32,932 shares — an estimated $1.18M sold.

Apogem Capital first reported a position in EVH in Q2 2021 and held it in 6 quarters. The position peaked at $1.18M in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • Apogem Capital reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 32,932 Evolent Health shares in Q4 2022, an estimated $1.18M.
  • Apogem Capital first reported a position in Evolent Health in Q2 2021 and held it in 6 quarters.
  • Apogem Capital's Evolent Health position peaked at $1.18M in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.